Celia Devenish
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Celia Devenish has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Noelyn Anne Hung
Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand
3 shared publications - Tania L. Slatter
Maurice Wilkins Centre for Biodiscovery, University of Auckland, Auckland 1142, New Zealand
3 shared publications - Anna Susan Howe
Department of General Practice and Primary Care, University of Auckland, New Zealand
2 shared publications - Beverley Lawton
Centre for Women's Health Research, Faculty of Health, Victoria University of Wellington, New Zealand
2 shared publications - Nikki Turner
Department of General Practice and Primary Care, The University of Auckland, Auckland, New Zealand
2 shared publications - Sara Filoche
Department of Obstetrics, Gynaecology and Women’s Health, University of Otago, Wellington, New Zealand
2 shared publications
Latest Publications
- Open Access
Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
Whether HPV is causative of pregnancy complications is uncertain. E6 and E7 affect functions underling preeclampsia (PET) in cultured trophoblasts, but whether E6 and E7 is produced in the placenta is uncertain. Here, we investigated whether E6/E7 was expressed in the placentae from pregnancies with PET, other pregnancy complications (fetal growth restriction (FGR) and diabetes mellitus), and uncomplicated pregnancies. Placental tissues collected from two geographical locations were subjected to RNAscope analyses of high- and low- risk E6/E7, and individual HPV types identified using an HPV array. High-risk E6/E7 expression was increased in both PET cohorts, (81% and 86% of patients positive for high-risk HPV DNA compared to 13% of control patients). Various HPV types were identified. Although HPV 18 was the most frequent in all cohorts, the majority of individuals had multiple HPV types (55% of the PET compared to 25% of the control cohort). Further evidence that E6 and E7 is present early when placental pathology underlying preeclampsia is established, is provided with the finding of high-risk E6/E7 in the first-trimester placenta anchoring trophoblast. In conclusion, E6/E7 expression and multiple HPV types were frequent in placentae from preeclampsia-complicated pregnancies.
Open AccessHuman Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
Whether HPV is causative of pregnancy complications is uncertain. E6 and E7 affect functions underling preeclampsia (PET) in cultured trophoblasts, but whether E6 and E7 is produced in the placenta is uncertain. Here, we investigated whether E6/E7 was expressed in the placentae from pregnancies with PET, other pregnancy complications (fetal growth restriction (FGR) and diabetes mellitus), and uncomplicated pregnancies. Placental tissues collected from two geographical locations were subjected to RNAscope analyses of high- and low- risk E6/E7, and individual HPV types identified using an HPV array. High-risk E6/E7 expression was increased in both PET cohorts, (81% and 86% of patients positive for high-risk HPV DNA compared to 13% of control patients). Various HPV types were identified. Although HPV 18 was the most frequent in all cohorts, the majority of individuals had multiple HPV types (55% of the PET compared to 25% of the control cohort). Further evidence that E6 and E7 is present early when placental pathology underlying preeclampsia is established, is provided with the finding of high-risk E6/E7 in the first-trimester placenta anchoring trophoblast. In conclusion, E6/E7 expression and multiple HPV types were frequent in placentae from preeclampsia-complicated pregnancies.
- Retracted
RETRACTED: Association of prior HPV vaccination with reduced preterm birth: A population based study